Company / EPS (Diluted)
Traws Pharma, Inc. EPS (Diluted) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$35.21
FY2024
5-year range
-$35.21 / -$0.91
FY2020-FY2024
Trend
-3769.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -3769% YoY in FY2024, a notable deviation from the 9-year average annual change of -511%.
Based on SEC 10-K filings.
-35.21 in FY2024.
Declined from $-0.96 to $-35.21 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 3769.2% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$35.21 | -3769.2% |
| FY2023 | -$0.91 | +5.2% |
| FY2022 | -$0.96 | +55.8% |
| FY2021 | -$2.17 | -45.6% |
| FY2020 | -$1.49 | +70.1% |
| FY2019 | -$4.99 | +87.6% |
| FY2018 | -$40.15 | -804.3% |
| FY2017 | -$4.44 | +57.9% |
| FY2016 | -$10.54 | -258.5% |
| FY2015 | -$2.94 | +80.8% |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026